AstraZeneca is to create a new vaccines unit as the Anglo-Swedish drugmaker plans for the future of its coronavirus shot beyond the pandemic.
The company said the reorganisation would bring together people who had previously been based in different parts of the business, and will be dedicated to the Covid-19 vaccine and tweaked versions to deal with new variants of Sars-CoV-2.
The move will not involve any extra investment in vaccines, but will make it easier for the company to continue making the Covid-19 shot over the long term.
AstraZeneca was chosen to develop the Covid-19 vaccine in conjunction with the University of Oxford, despite the drugmaker’s limited experience of large-scale vaccine production beyond a nasal spray for flu.
Unlike
Read more on theguardian.com